Evidence map›Paper›PMID 36678839›Full record

ReviewPharmaceutics2023

Microfluidic Manipulation for Biomedical Applications in the Central and Peripheral Nervous Systems.

Zhenghang Li, Zhenmin Jiang, Laijin Lu, Yang Liu

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zhenghang LiDepartment of Hand Surgery, Center of Orthopedics, The First Hospital of Jilin University, Changchun 130021, China.
Zhenmin JiangDepartment of Hand Surgery, Center of Orthopedics, The First Hospital of Jilin University, Changchun 130021, China.
Laijin LuDepartment of Hand Surgery, Center of Orthopedics, The First Hospital of Jilin University, Changchun 130021, China.
Yang LiuDepartment of Hand Surgery, Center of Orthopedics, The First Hospital of Jilin University, Changchun 130021, China.ORCID 0000-0002-0974-6736
Jilin University · CN

Funding

National Natural Science Foundation of China 81901245the Project of the Department of Science and Technology of Jilin Province YDZJ202201ZYTS673
6 · The paper itself

Abstract

Physical injuries and neurodegenerative diseases often lead to irreversible damage to the organizational structure of the central nervous system (CNS) and peripheral nervous system (PNS), culminating in physiological malfunctions. Investigating these complex and diverse biological processes at the macro and micro levels will help to identify the cellular and molecular mechanisms associated with nerve degeneration and regeneration, thereby providing new options for the development of new therapeutic strategies for the functional recovery of the nervous system. Due to their distinct advantages, modern microfluidic platforms have significant potential for high-throughput cell and organoid cultures in vitro, the synthesis of a variety of tissue engineering scaffolds and drug carriers, and observing the delivery of drugs at the desired speed to the desired location in real time. In this review, we first introduce the types of nerve damage and the repair mechanisms of the CNS and PNS; then, we summarize the development of microfluidic platforms and their application in drug carriers. We also describe a variety of damage models, tissue engineering scaffolds, and drug carriers for nerve injury repair based on the application of microfluidic platforms. Finally, we discuss remaining challenges and future perspectives with regard to the promotion of nerve injury repair based on engineered microfluidic platform technology.

Indexed as

damage modelsdrug-delivery systemmicrofluidic platformsnerve injury repairtissue engineering scaffold

Identifiers

PMID36678839
PMCPMC9862045
OpenAlexW4313824831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.